Introduction
In recent years it has become recognized that tumours of many organs may produce hormones normally originating in quite different organs and tissues and that these hormones may have endocrine effects on their target organs.
On occasion multiple tumours co-exist in different endocrine tissues in the same individual, constituting the multiple endocrine adenoma syndrome (Cooke et al., 1960) . Alternatively a single tumour may elaborate more than one hormonal substance and produce diverse endocrinological effects (Shames, Dhurandhar & Blackard, 1968) , and this ability to produce multiple hormones probably reflects embryological potentialities of cells of a single tissue.
We report here a patient whose pancreatic tumour seemed capable of producing insulin, with consequent hypoglycaemia, and also serotonins, producing the carcinoid syndrome. In addition the fact that a large duodenal ulcer co-existed and the patient was a young female might suggest excessive gastrin production.
The value of arteriography is demonstrated both in showing the primary lesion in the pancreas and the extent of metastases in the liver.
Case report
A 22-year-old girl was admitted to hospital complaining of pain in the right hypochondrium for 2 weeks, nausea, vomiting, rather loose stools and loss of energy for 6 weeks and marked loss of weight for 4 months.
Examination revealed a pale thin girl with a dry flaking skin. The liver was palpable four finger breadths below the costal margin and was firm and smooth. There were no other significant physical signs. X-ray of the chest showed only a raised right diaphragm, and barium meal showed a large ulcer crater in the duodenum. She was treated with diet and bed-rest and by the following week the pain and (Crawford, 1931; Nadler & Wolfer, 1929; McFadzean & Yeung, 1956; MacDonald, 1957; Klein & Klein, 1959; Lowbeer, 1961) , and this seemed possible in this patient even after liver biopsy. Arteriography was of great value in demonstrating the small pancreatic lesion and the extent of metastatic spread, and had the liver biopsy not demonstrated the tumour, arteriography would have obviated the need for laparotomy. In view of the primary pancreatic tumour and the high levels of insulin in the blood, this must be regarded as a functioning islet-cell tumour, despite the lack of 3-cell granules (Marks & Samols, 1966) .
In this patient, however, there was also excess of 5-hydroxyindoles, and this might thus be termed an atypical carcinoid tumour (Oates & Sjoerdsma, 1962) arising in the pancreas.
Multiple endocrine syndromes may be due to tumours of more than one endocrine organ (Cooke et al., 1960) (Dutta & Wallace, 1968) . Our patient appears to be only the third reported in whom the carcinoid syndrome has occurred secondary to an insulin-secreting islet-cell adenoma of the pancreas (Van Der Sluys Veer et al., 1964; Gloor, Pletscher & Hardmeier, 1964) . In view of the large duodenal ulcer, which is an unusual finding in a young female, it seems possible that the tumour may also have secreted gastrin or a gastrin-like peptide, but unfortunately no measurements relevant to this were made. It seems unlikely that the duodenal ulcer was secondary to stimulation of gastric secretion by hypoglycaemia (Marks & Rose, 1965) , since the ulcer was clearly demonstrated radiologically before the onset of symptoms of hypoglycaemia. The production of many hormones by a single tumour raises the interesting speculation that cells of endocrine tissues may be potentially biochemically multipotent, and that in the modifications resulting in tumour formation suppressed biochemical pathways might be re-established (Peart, 1966) .
A further mechanism for the hypoglycaemia may also be considered. It has been shown (Silverstein, Wakim & Bahn, 1966 ) that tryptophan metabolites can produce hypoglycaemia in mice and that levels of these metabolites may be increased in patients with tumours, particularly when associated with hypoglycaemia. Low blood sugars have been recorded in patients with carcinoid tumours (Kahler & Heilmeyer, 1961; Schmid, Wenzl & Uehlinger, 1963 ) but this does not seem to be more common or more severe than with tumours of other tissues when levels of 5-hydroxyindoles are not as high. It thus seems unlikely that the tryptophan metabolites themselves were the cause of the profound hypoglycaemia in this patient, particularly in view of the raised serum insulin levels.
In patients with the carcinoid syndrome, the excess production of 5-hydroxyindoles may divert tryptophan away from the formation of nicotinamide, and produce a clinical state resembling pellagra of nutritional origin. The diarrhoea, and the presence of skin changes in this patient would be consistent with this mechanism, and the excretion of n-methyl nicotinamide in the urine was below the lower limit of normal, providing biochemical confirmation. The absence of xanthurenic acid in the urine suggested that pyridoxine deficiency was unlikely to explain this finding.
Clinical examination of the nervous system suggested a peripheral neuropathy, and this was borne out by slowing of electrical conduction in the peripheral nerves and by the histological findings on motor point biopsy. Peripheral neuropathy is described in hypoglycaemia (British Medical Journal, 1964) and the muscle wasting and creatinuria in our patient may have been at least partly secondary to the peripheral neuropathy.
A further point of interest was the prompt and dramatic response of the otherwise intractable hypoglycaemia to diazoxide (Fig. 1) . There is some evidence that one mechanism of action of diazoxide may be to inhibit the secretion of insulin (Grant, Piesowicz & Buckler, 1966; Howell & Taylor, 1966 (1968) . Severe hypoglycaemia and birth weight above the mean for their gestational age were the main features of the three cases reported by Combs, Grunt & Brandt (1966) . The principal features of the previously reported cases are shown in Table 1 .
Two further cases are reported who developed hypocalcaemia, in addition to the main features already described. One survived and now has hemihypertrophy. 
